1. Home
  2. TMDX vs MIAX Comparison

TMDX vs MIAX Comparison

Compare TMDX & MIAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • MIAX
  • Stock Information
  • Founded
  • TMDX 1998
  • MIAX 2007
  • Country
  • TMDX United States
  • MIAX United States
  • Employees
  • TMDX N/A
  • MIAX N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • MIAX Investment Bankers/Brokers/Service
  • Sector
  • TMDX Health Care
  • MIAX Finance
  • Exchange
  • TMDX Nasdaq
  • MIAX Nasdaq
  • Market Cap
  • TMDX 3.9B
  • MIAX 3.4B
  • IPO Year
  • TMDX 2019
  • MIAX 2025
  • Fundamental
  • Price
  • TMDX $115.69
  • MIAX $42.10
  • Analyst Decision
  • TMDX Buy
  • MIAX Buy
  • Analyst Count
  • TMDX 11
  • MIAX 6
  • Target Price
  • TMDX $125.40
  • MIAX $40.60
  • AVG Volume (30 Days)
  • TMDX 958.8K
  • MIAX 799.2K
  • Earning Date
  • TMDX 10-27-2025
  • MIAX 01-01-0001
  • Dividend Yield
  • TMDX N/A
  • MIAX N/A
  • EPS Growth
  • TMDX 2163.11
  • MIAX N/A
  • EPS
  • TMDX 2.02
  • MIAX 0.02
  • Revenue
  • TMDX $531,292,000.00
  • MIAX $1,255,413,000.00
  • Revenue This Year
  • TMDX $38.87
  • MIAX N/A
  • Revenue Next Year
  • TMDX $20.70
  • MIAX N/A
  • P/E Ratio
  • TMDX $57.33
  • MIAX $2,022.63
  • Revenue Growth
  • TMDX 48.09
  • MIAX 19.63
  • 52 Week Low
  • TMDX $55.00
  • MIAX $28.63
  • 52 Week High
  • TMDX $146.98
  • MIAX $42.89
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 49.53
  • MIAX N/A
  • Support Level
  • TMDX $109.77
  • MIAX N/A
  • Resistance Level
  • TMDX $115.90
  • MIAX N/A
  • Average True Range (ATR)
  • TMDX 4.84
  • MIAX 0.00
  • MACD
  • TMDX -0.12
  • MIAX 0.00
  • Stochastic Oscillator
  • TMDX 31.21
  • MIAX 0.00

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About MIAX Miami International Holdings Inc. Common Stock

Miami International Holdings Inc is a technology-driven leader in building and operating regulated financial marketplaces across multiple asset classes and geographies. Its MIAX Exchange marketplaces are enabled by its in-house built, proprietary technology. It maintains a broad portfolio of U.S. exchange and clearing licenses, in both securities and futures. The company operates markets across a diverse number of asset classes including options and cash equities as well as futures and options on futures.

Share on Social Networks: